Drug intelligence / Profile preview

MLI-AuNCs

Development stage
Preclinical
Lead developer
Huazhong University of Science and Technology
Modality
Nanoparticles → Drug Delivery Systems
Administration
Intraperitoneal, Intravenous, Intranasal, Oral
01

Overview

**MLI-AuNCs** is an investigational, thermosensitive lipid-bilayer-coated gold nanocage formulation co-loading indocyanine green and monophosphoryl lipid A for near-infrared-triggered immunogenic phototherapy of malignant melanoma. Gold nanocages and indocyanine green absorb near-infrared light to generate local heat and reactive oxygen species for combined photothermal and photodynamic tumor destruction, while monophosphoryl lipid A provides Toll-like receptor 4-mediated innate immune stimulation. In murine melanoma studies, the formulation accumulated in tumors following intravenous administration and was intended to promote dendritic-cell maturation and effector T-cell responses that could limit metastatic spread and relapse. ([sciencedirect.com](https://www.sciencedirect.com/science/article/pii/S1742706122000629))

Other names
MLI-AuNCsMPLA lipid bilayer-enveloped and ICG-loaded gold nanocages
02

Targets

TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on MLI-AuNCs.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MLI-AuNCs.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call